The FDA has accepted for Priority Review the sBLA for aflibercept injection 8mg for the treatment of macular edema following RVO and for monthly dosing in approved indications.

Credit: SUPERMAO/Shutterstock. Vantage Biosciences has dosed the first subject in the randomised Phase II trial of oral therapy VX-01 to treat non-proliferative diabetic retinopathy (NPDR). The ...

As the burden of diabetes continues to rise in India, diabetic retinopathy has emerged as one of its most debilitating complications—often leading to irreversible vision loss if left undiagnosed.

What treatment options are available for diabetic retinopathy? Dr. Daraius Shroff: The treatment of diabetes depends on the stage of diabetes and includes laser photocoagulation, intravitreal ...

Background: Diabetic retinopathy, a major microvascular complication of diabetes, significantly contributes to global blindness. Emerging evidence suggests a potential association between depression ...

It is currently scaling an AI solution that it began piloting in 2022: Digital Diagnostics’ AI system that autonomously diagnoses diabetic retinopathy. The system, called the LumineticsCore ...

This study highlights the power of AVAVA's proprietary Focal Point Technology™, redefining energy-based ... At the heart of this technology is a ring-shaped laser beam that penetrates deeply into the ...